The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women
Open accessAbstract
Abstract —The purpose of this study was to determine whether transdermal estradiol and intravaginal progesterone given in doses to mimic the premenopausal state would lower blood pressure (BP) in postmenopausal women. Fifteen healthy postmenopausal women were studied in each of 3 conditions: on placebo, after 8 weeks of transdermal estradiol 0.2 mg twice per week, and again 2 weeks after addition of intravaginal progesterone 300 mg/d. Women were studied at each point after 2 days of 100 mmol/d sodium intake. Twenty-four–hour ambulatory BP monitoring was performed, and blood was assayed for estradiol, progesterone, and hormones of the renin-angiotensin-aldosterone system (RAAS). ANOVA with pairwise comparisons was used for analysis. Urinary sodium excretion was similar at each time point. Levels of estrogen and progesterone similar to those in premenopausal women were achieved. On estradiol, nocturnal systolic BP (110±3 mm Hg), diastolic BP (63±2 mm Hg), and mean BP (77±2 mm Hg) fell significantly ( P <0.02) compared with placebo systolic BP (116±2 mm Hg), diastolic BP (68±2 mm Hg), and mean BP (82±2 mm Hg). Daytime BP followed the same trend but was significantly lower only for mean BP. There was no activation of the RAAS. The addition of progesterone resulted in no further fall in BP but a significant activation of the RAAS. Thus, contrary to what is often assumed, administration of estradiol with or without progesterone not only did not raise BP but rather substantially lowered BP. This BP-lowering effect may be responsible for the lower incidence of hypertension in premenopausal than in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
Schunkert, H., Danser, A. H. J., Hense, H.-W., Derkx, F. H. M., Ku¨rzinger, S., & Riegger, G. A. J. (1997) · Circulation · doi:10.1161/01.cir.95.1.39 · Cited by 438
ORAL CONTRACEPTIVES AND HYPERTENSION
Woods, J. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90690-3 · Cited by 131
Hassager, C., Riis, B. J., Strøm, V, Guyene, T. T., & Christiansen, C. (1987) · Circulation · doi:10.1161/01.cir.76.4.753 · Cited by 124
Jespersen, C. M., Arnung, K., Hagen, C., Hilden, T., Nielsen, F., Nielsen, M. D., & Giese, J. (1983) · Journal of Hypertension · doi:10.1097/00004872-198312000-00007 · Cited by 39
Cited by
Gender differences in the regulation of blood pressure
Reckelhoff, J. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1199 · Cited by 1,268
Dubey, R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00527-2 · Cited by 571
Comprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 310
Gender and the renin–angiotensin–aldosterone system
Komukai, K., Mochizuki, S., & Yoshimura, M. (2010) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00854.x · Cited by 291
Transdermal Estrogen Replacement Therapy Decreases Sympathetic Activity in Postmenopausal Women
Vongpatanasin, W., Tuncel, M., Mansour, Y., Arbique, D., & Victor, R. G. (2001) · Circulation · doi:10.1161/01.cir.103.24.2903 · Cited by 203
Ovarian Cycle and Sympathoexcitation in Premenopausal Women
Carter, J. R., Fu, Q., Minson, C. T., & Joyner, M. J. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.202598 · Cited by 105
“However, other data suggest that only progesterone activates the RAAS, whereas estrogen might inhibit the activation of this system.(30,31) Szmuilowicz et al(27) reported that progesterone may directly contribute to increased luteal phase aldosterone production independent of the RAAS.”
BackgroundFu, Q., VanGundy, T. B., Shibata, S., Auchus, R. J., Williams, G. H., & Levine, B. D. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.151787 · Cited by 62
Self-citationVestergaard, P., Hermann, A. P., Stilgren, L., Tofteng, C. L., Sørensen, O. H., Eiken, P., Nielsen, S. P., & Mosekilde, L. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00181-6 · Cited by 60
Xu, X., Xiao, J.-C., Luo, L.-F., Wang, S., Zhang, J.-P., Huang, J.-J., Liu, M.-L., Liu, C.-G., Xu, K.-Q., Li, Y.-J., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.041 · Cited by 53
Modulation of blood pressure by estrogen: A modeling analysis
Layton, A. T. (2026) · Mathematical Biosciences · doi:10.1016/j.mbs.2025.109610 · Cited by 1
Metadata
- Authors
- Seely, E. W., Walsh, B. W., Gerhard, M. D., & Williams, G. H.
- Venue
- Hypertension
- Published
- 1999-05
- Volume
- 33
- Issue
- 5
- Pages
- 1190-1194
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2062402055
- Cited by
- 176
- References
- 6
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.